My Cart

HRSV Glycoprotein (RSV-G)

HRSV Glycoprotein (RSV-G) Product List

  • Product Category

    Antibody (2)

  • Product Status

    Launched (2)

  • Species

    Mouse (2)

  • Tag

    Human IgG1 (2)

  • Conjugate

    Unconjugated (2)

HRSV Glycoprotein (RSV-G) Background

The two major glycoproteins on the surface of the RSV virion, the attachment glycoprotein (G) and the fusion (F) glycoprotein, control the initial phases of infection. The central region of the G protein contains a 13-amino acid highly conserved domain, partially overlapping the cysteine noose domain with 4 cysteines linked 1–4 and 2–3, followed by a highly basic heparin-binding domain (HBD). The HBD is the likely attachment site for heparan sulfate (HS) found on the surface of most cells. A peptide from the G protein HBD (amino acids 184–198) binds efficiently to HEp-2 cells and inhibits RSV infection.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
FepixnebartLY-3016859Phase 2 ClinicalEli Lilly And CompanyDiabetic Neuropathies; Osteoarthritis, Knee; Diabetic Nephropathies; Osteoarthritis; Low Back Pain
Details
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland